Baidu
map

FDA:脂肪肉瘤治疗药物Halaven批准上市

2016-02-01 Mechront 译 MedSci原创

FDA批准Halaven治疗无法手术切除或转移性脂肪肉瘤。Halaven是第一个批准用于脂肪肉瘤治疗的药物,可改善改善患者的生存,可增加整体约7个月的生存期。脂肪肉瘤是软组织肉瘤的一种,发生于脂肪细胞。数据显示,2014年美国约有12000例软组织肉瘤患者。通过对143名无法手术切除或转移性脂肪肉瘤的研究发现, Halaven治疗的患者整体生存期达15.6个月,其他化疗药物达卡巴嗪治疗的患者整体生

FDA批准Halaven治疗无法手术切除或转移性脂肪肉瘤。Halaven是第一个批准用于脂肪肉瘤治疗的药物,可改善改善患者的生存,可增加整体约7个月的生存期。

脂肪肉瘤是软组织肉瘤的一种,发生于脂肪细胞。数据显示,2014年美国约有12000例软组织肉瘤患者。

通过对143名无法手术切除或转移性脂肪肉瘤的研究发现, Halaven治疗的患者整体生存期达15.6个月,其他化疗药物达卡巴嗪治疗的患者整体生存期8.4个月。

Halaven患者最常见的副作用是疲劳、恶心、脱发、周围神经病变、腹痛、发热等,此外Halaven还会导致白细胞和电解质钾钙的降低。Halaven严重的副反应包括白细胞的减少导致的严重感染,进而造成死亡;周围神经病变;胚胎发育异常;QTc延长等可能导致死亡的风险。

原始出处:

FDA approves first drug to show survival benefit in liposarcoma


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=341325, encodeId=7a2d341325e2, content=中国什么时候可以上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=475f2428505, createdName=123af4b7m16暂无昵称, createdTime=Mon Aug 27 15:25:03 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024523, encodeId=43b620245230c, content=<a href='/topic/show?id=937c84530c' target=_blank style='color:#2F92EE;'>#Halaven#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8453, encryptionId=937c84530c, topicName=Halaven)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Wed Sep 21 22:30:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921639, encodeId=189a192163943, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed May 25 11:30:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077035, encodeId=ebf520e7035fe, content=<a href='/topic/show?id=955d226045' target=_blank style='color:#2F92EE;'>#ALA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2260, encryptionId=955d226045, topicName=ALA)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Tue Jun 28 16:30:00 CST 2016, time=2016-06-28, status=1, ipAttribution=)]
    2018-08-27 123af4b7m16暂无昵称

    中国什么时候可以上市

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=341325, encodeId=7a2d341325e2, content=中国什么时候可以上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=475f2428505, createdName=123af4b7m16暂无昵称, createdTime=Mon Aug 27 15:25:03 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024523, encodeId=43b620245230c, content=<a href='/topic/show?id=937c84530c' target=_blank style='color:#2F92EE;'>#Halaven#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8453, encryptionId=937c84530c, topicName=Halaven)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Wed Sep 21 22:30:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921639, encodeId=189a192163943, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed May 25 11:30:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077035, encodeId=ebf520e7035fe, content=<a href='/topic/show?id=955d226045' target=_blank style='color:#2F92EE;'>#ALA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2260, encryptionId=955d226045, topicName=ALA)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Tue Jun 28 16:30:00 CST 2016, time=2016-06-28, status=1, ipAttribution=)]
    2016-09-21 cathymary
  3. [GetPortalCommentsPageByObjectIdResponse(id=341325, encodeId=7a2d341325e2, content=中国什么时候可以上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=475f2428505, createdName=123af4b7m16暂无昵称, createdTime=Mon Aug 27 15:25:03 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024523, encodeId=43b620245230c, content=<a href='/topic/show?id=937c84530c' target=_blank style='color:#2F92EE;'>#Halaven#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8453, encryptionId=937c84530c, topicName=Halaven)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Wed Sep 21 22:30:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921639, encodeId=189a192163943, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed May 25 11:30:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077035, encodeId=ebf520e7035fe, content=<a href='/topic/show?id=955d226045' target=_blank style='color:#2F92EE;'>#ALA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2260, encryptionId=955d226045, topicName=ALA)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Tue Jun 28 16:30:00 CST 2016, time=2016-06-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=341325, encodeId=7a2d341325e2, content=中国什么时候可以上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=475f2428505, createdName=123af4b7m16暂无昵称, createdTime=Mon Aug 27 15:25:03 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024523, encodeId=43b620245230c, content=<a href='/topic/show?id=937c84530c' target=_blank style='color:#2F92EE;'>#Halaven#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8453, encryptionId=937c84530c, topicName=Halaven)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Wed Sep 21 22:30:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921639, encodeId=189a192163943, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Wed May 25 11:30:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077035, encodeId=ebf520e7035fe, content=<a href='/topic/show?id=955d226045' target=_blank style='color:#2F92EE;'>#ALA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2260, encryptionId=955d226045, topicName=ALA)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Tue Jun 28 16:30:00 CST 2016, time=2016-06-28, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map